Search results
Gilead Sciences: Native Health Navigator Program Connects
3BL CSRwire· 11 hours agoOlivia Sloan was pursuing a career in health policy and research when her father was diagnosed with...
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 7 days agoComprehensive SWOT analysis highlighting Gilead Sciences Inc's strategic positioning in the...
Taking a look at what insiders are doing to gauge the Gilead Sciences, Inc.
Knox Daily· 6 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Gilead Sciences, Inc. shares ...
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks· 6 days agoFree Report) has recently been on Zacks.com's list of the most searched stocks. During this period, the Zacks Medical - Biomedical and Genetics industry, which Gilead falls in, has lost 0.4% ...
Decoding Gilead Sciences's Options Activity: What's the Big Picture? - Gilead Sciences (NASDAQ:GILD)
Benzinga· 5 days agoLoading... Loading... Financial giants have made a conspicuous bullish move on Gilead Sciences. Our analysis of options history for Gilead</ ...
Will Gilead Sciences Stock Recover To Its Pre-Inflation Shock Highs Of Around $75?
Forbes· 7 days agoGILD stock was trading at around $62 in early June 2022, just before the Fed started increasing...
US FDA approves expanded use of Bristol Myers' cancer cell therapy
Reuters· 7 hours ago, opens new tab cancer cell therapy Breyanzi for the treatment of adults with a type of blood cancer...
Gilead’s FOCUS Program Helps Zero In on Early HIV
3BL CSRwire· 6 days agoA 22-year-old college student who didn’t feel well was treated at an urgent care facility in Baton Rouge, Louisiana and expected to recover soon. When the test came back positive, the student ...
Kite and Arcellx to start Phase 3 trial for myeloma therapy By Investing.com
Investing.com· 6 days agoREDWOOD CITY, Calif. & SANTA MONICA, Calif. - Kite, a Gilead Company (NASDAQ: GILD), and Arcellx,...
One stock is dragging down the S&P 500's earnings growth
Yahoo Finance· 2 days agoWhen removing a few other companies from the sector, the S&P 500's earnings growth would shoot even...